Wandercraft has acquired Ekso Bionics in a move that Wandercraft described as “bringing together two leaders in robotic mobility.”
Wandercraft — based in Paris and New York City — and Ekso Bionics, based in San Rafael, California, announced the deal on Oct. 1. Wandercraft bought the exoskeleton company from ChronoScale Holdings Corp. (Nasdaq: CHRN).
“The two companies contribute complementary technologies and decades of combined experience to help more people to stand, walk and participate more fully in everyday life,” the announcement said. “Together, they form the world’s leading medical exoskeleton company, offering an unmatched combination of technology, clinical experience and global reach.”
In healthcare, Wanderlust is best known for its gait-training Atalante rehabilitation exoskeleton and its Eve walking exoskeleton for people with spinal cord injuries. Ekso Bionics is best known for its Indego Personal walking exoskeleton.
“The acquisition combines Wandercraft’s expertise in advanced robotics and physical AI [artificial intelligence] and its leadership in EMEA [Europe, Middle East, Africa] with Ekso Bionics’ strong U.S. presence, extensive clinical experience, and commercial reach,” the announcement added. “Both companies have been trailblazers in medical exoskeletons, driving technological innovation, R&D and clinical research. The combination creates a global powerhouse in robotic mobility, with a broader portfolio of medical exoskeletons spanning the continuum of care, from rehabilitation to everyday personal mobility.”
“We share a vision for how robotics can empower people whose mobility has been unfairly limited by injury or disease,” said Matthieu Masselin, Wandercraft’s co-founder and CEO. “Both companies have pioneered advanced technologies to help people stand, walk and participate more fully in everyday life. By bringing together our products, teams and clinical relationships on both sides of the Atlantic, we have an exceptional opportunity to expand access to robotic mobility worldwide, reach more patients and rehabilitation professionals, and help more people experience the independence and connection that upright mobility can offer.”
The transaction was signed and closed simultaneously. Financial terms were not disclosed.
